what are the Recommendation for SGLT2i
Referenced studies that support the recommendation are summarized
in the Online Data Supplements.?
In patients with symptomatic chronic HFrEF, SGLT2i are recommended to reduce hospital- ization for HF and cardiovascular mortality, irre- spective of the presence of type 2 diabetes.